What Chemify does
Chemify (chemify.io) is a private AI-for-science company building “Chemputation”—a closed-loop digital-to-physical workflow that aims to automate small-molecule and other makeable chemistry by combining machine-learning molecule design with a universal chemical programming language and automated robotic synthesis. Chemify’s stated approach translates target molecules into “chemical code” that can run on its robotic systems to enable design–make–test–analyze cycles, with the goal of removing the synthesis bottleneck and reducing failure modes tied to unverified design outputs.
Commercially, Chemify positions its platform as capacity-backed access rather than a static library: it offers Chemify Genesis as an executable loop that integrates search/retrosynthesis and makes it actionable through Chemifarm execution and analytics, with “reserved” lanes of compute and physical lab capacity for partner campaigns. Chemify describes Chemifarm facilities as the physical execution layer for Chemputation.
Strategically, Chemify appears to be moving from technology development to scaled deployment: it states that it opened its first Chemifarm in Maryhill (Glasgow) in 2025 and has “global expansion underway,” while continuing to attract institutional and corporate investors and partners (e.g., Zeon Ventures; Sanacor; and grant funding for tuberculosis and malaria lead discovery).